EDGAR Filing Documents for 0001193125-16-560394

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001193125-16-560394

Filing Date

2016-04-28

Accepted

2016-04-27 20:59:12

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	d177131dsc13d.htm	SC 13D	54395
	Complete submission text file	0001193125-16-560394.txt		55762

Mailing Address

Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200

SYNTA PHARMACEUTICALS CORP (Subject) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82674 | Film No.: 161596860
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034

Business Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034 949-725-4277

Madrigal Pharmaceuticals, Inc. (Filed by) CIK: 0001673226 (see all company filings)

IRS No.: 453050834 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D